In recent years, semaglutide has emerged as a breakthrough medication in the treatment of type 2 diabetes, obesity, and even heart health. This injectable medication belongs to the GLP-1 receptor agonists class, which works by mimicking the glucagon-like peptide-1 (GLP-1) hormone that plays a significant role in blood sugar control, https://tysonqjtfr.blog2news.com/31575715/semaglutide-a-revolutionary-medication-for-weight-loss-diabetes-and-cardiovascular-health